info@bivictrix.com
September 19th, 2023
BiVictriX Interim results for the six months ended 30 June 2023
Read more
August 23rd, 2023
US Patent Granted Providing Broad Protection for BVX001
Read more
August 08th, 2023
Result of General Meeting Completion of Fundraise
Read more
July 19th, 2023
Result of Conditional Fundraise
Read more
July 19th, 2023
Proposed Fundraise in excess of £2 million
Read more
July 17th, 2023
Positive final data in second preclinical efficacy study
Read more
June 19th, 2023
Positive interim data in second preclinical efficacy study
Read more
June 06th, 2023
BiVictriX nominates clinical candidate for BVX001
Read more
May 04th, 2023
Result of Annual General Meeting
Read more
March 31st, 2023
Publication of Annual Report and Notice of AGM
Read more
March 30th, 2023
Full year results for the twelve months ended 31 December 2022
Read more
March 01st, 2023
Appointment Of Alex Hughes As CFO
Read more
Load more
Quick links
Head office
Mereside
Alderley Park
Alderley Edge
Cheshire, UK
SK10 4TG info@bivictrix.com
Copyright: BiVictriX Therapeutics plc 2023.

All Rights Reserved. Design & Development By Online Web Studio